Aarkstore Enterprise Positron Emission Tomography (PET) Markets
More Reports
Positron Emission Tomography (PET) Markets
Molecular Diagnostics in Cancer Testing
Molecular Diagnostics in Infectious Disease Testing
Companion Diagnostics in Personalized Medicine and Cancer Therapy
Ultrasound Markets
Cancer Diagnostic Testing World Markets
Nuclear Cardiology Markets
Medical Imaging Markets
Cancer Vaccines Markets
European Medical Imaging Markets
Respiratory Therapeutics and Devices Markets
India’s In Vitro Diagnostic Testing Industry
The medical imaging segments are poised for a major new phase of growth fueled by the availability of new technology coming out of the computer and digital information technology segment. Continuous improvements in technology are resulting in a growing number of new imaging tests that combine high levels of accuracy with rapid, easy-to-use product formats. Part of that medical imaging improvement is coming from positron emission tomography (PET). PET is a scanning technique used in combination with small amounts of radio-labeled compounds to visualize the anatomy and function of the brain. The purpose of this Publications report is to describe the specific market segment of the diagnostics medical imaging market called PET scanning. This sector includes all of the generally accepted imaging activities that are currently used in PET, including equipment for PET, PET/CT, SPECT and the use of radiopharmaceuticals for imaging. It examines these clinical measurement devices and their reagents and supplies as used in hospitals and clinics. It also reviews associated clinical market segments in which PET scanning has taken a prominent role including cancer treatment, cardiology and neurology imaging markets.
Table of Contents :
1. Overview 6
1.1 Statement of Report 6
1.2 Scope of the Report 8
1.3 Objectives 9
1.4 Methodology 9
1.5 Executive Summary 9
2. Overview of Diagnostic Point of Care Testing 11
2.1 Key Issues in the Point of Care Diagnostic Testing Sector 11
2.1.1 Current Market Trends and Drivers 11
2.1.2 Effectiveness of POCT 12
2.1.3 New Growth Areas for POCT 13
2.1.4 Advantages of POCT in a Clinical Setting 13
2.1.5 Pricing and Reimbursement Issues 13
2.1.6 Key Customer Segments 13
2.2 Global Point of Care Marketplace 13
2.3 Shifts from Central-Lab Testing to POCT 15
2.4 Geographical Distribution 15
2.5 Emerging New Technologies 16
2.6 Challenges of POCT 17
2.7 Key Issues for POCT 17
2.7.1 Locations of POCT 17
2.7.2 Hospital Lab Rapid Tests 18
2.7.3 Doctor’s Office Laboratory 18
2.7.4 Non-Hospital POCT 18
2.7.5 Home Monitoring 19
2.7.6 Milestones in Technology Development 20
2.7.7 Drive for Decentralization from Lab to Patient 20
2.7.8 Expanded Reimbursement 20
2.7.9 Competitive Landscape for POCT 23
2.8 The Future of POCT 23
3. POC and Rapid Testing: Market Analysis: Size, Background, Growth, Share and Competitors 24
3.1 Global POCT Market 26
3.2. U.S. Point of Care Markets 27
3.3. European POCT Market 32
3.4. Japanese POCT Market 35
For more information please visit link:
http://www.aarkstore.com/reports/Positron-Emission-Tomography-PET-Markets-1338.html
Neel
Aarkstore Enterprise
Phone:08149852585
Email:enquiry@aarkstore.com
URL:www.aarkstore.com
Processing your request, Please wait....
